I don't know if that will happen.
The stock seems to be in "wait and see" mode, with SUCCEED/Ridaforolimus acting as the albatross around shareholders throats.
I think we'll all get a sense of how the data is by watching the stock after the next few weeks (closer to Q1). Because, YOU KNOW, data will be leaked to one person, and one person will tell another person, etc.
Be careful for the B.S. that's been happening as of late in a few stocks where (I believe) a large short position hammers the stock and creates massive stop loss orders, driving the stock down substantially, covering their position. I've seen this happen a few times ahead of positive data.
